6RBC image
Deposition Date 2019-04-10
Release Date 2020-05-13
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6RBC
Keywords:
Title:
X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor KB1157
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.77 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Glutamate carboxypeptidase 2
Gene (Uniprot):FOLH1
Chain IDs:A
Chain Length:707
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Novel beta- and gamma-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.
J.Med.Chem. 63 3261 3273 (2020)
PMID: 32097010 DOI: 10.1021/acs.jmedchem.9b02022

Abstact

Prostate-specific membrane antigen (PSMA) is an excellent biomarker for the early diagnosis of prostate cancer progression and metastasis. The most promising PSMA-targeted agents in the clinical phase are based on the Lys-urea-Glu motif, in which Lys and Glu are α-(l)-amino acids. In this study, we aimed to determine the effect of β- and γ-amino acids in the S1 pocket on the binding affinity for PSMA. We synthesized and evaluated the β- and γ-amino acid analogues with (S)- or (R)-configuration with keeping α-(l)-Glu as the S1'-binding pharmacophore. The structure-activity relationship studies identified that compound 13c, a β-amino acid analogue with (R)-configuration, exhibited the most potent PSMA inhibitory activity with an IC50 value of 3.97 nM. The X-ray crystal structure of PSMA in complex with 13c provided a mechanistic basis for the stereochemical preference of PSMA, which can guide the development of future PSMA inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures